GlassScriptPhysician profile
John D Puskas
NPI 1457440018
$332,449.55
in general payments reported to CMS, 2019-2025
19 companies · $4,636 in 2025
The $4,636 reported for 2025 was more than what 81% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138K · 2020: $115K · 2021: $18K · 2022: $12K · 2023: $31K · 2024: $15K · 2025: $4,636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $2,239 · Food and Beverage: $2,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,762.50 |
| Travel and Lodging | $2,238.77 |
| Food and Beverage | $2,134.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scanlan International INC | $186,091.78 | 2019-2020 | |
| Medtronic Vascular, INC. | $65,361.09 | 2019-2020 | |
| Medtronic, INC. | $39,705.77 | 2021-2025 | Octopus, Penditure, Symplicity G3 |
| Artivion, INC. | $30,682.09 | 2019-2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Edwards Lifesciences Corporation | $7,672.18 | 2022-2024 | |
| Atricure, INC. | $883.32 | 2023-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Arthrex, INC. | $531.26 | 2025 | |
| Vascular Graft Solutions INC | $416.45 | 2019-2025 | Vest |
| Abbott Laboratories | $322.03 | 2022-2025 | Sjm Masters Series |
| Heartflow, INC. | $138.18 | 2024 | |
| Bolton Medical INC | $131.64 | 2024 | Treo Abdominal Stent-Graft System |
| Maquet Cardiovascular L.L.C. | $126.58 | 2023 | Acrobat-I Stabilizer |
| Terumo Cardiovascular Systems Corporation | $118.56 | 2019 | |
| Aesculap Ag | $90.91 | 2019 | |
| Intuitive Surgical, INC. | $84.61 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $66.63 | 2024 | Keytruda |
| Bardy Diagnostics, INC. | $13.97 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.50 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Puskas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.